Medicaid

Feldesman is pleased to announce partners Adam J. Falcone, Gabriel S. García, and Steve Kuperberg will speak at the National Association of Community Health Centers’ (NACHC) CHI - Community Health Conference, taking [...]

Washington Court Rejects State Medicaid Agency’s Payment Methodology for FQHC Reimbursement On April 23, 2026, the Superior Court of the State of Washington, Spokane County, held[1] that Washington’s state Medicaid agency, the [...]

On April 8, 2026, the Centers for Medicare and Medicaid Services (CMS) issued guidance directing states to restrict Medicaid and Children’s Health Insurance Program (CHIP) eligibility for certain categories of non-citizens effective [...]

Feldesman Partner Steve Kuperberg was recently quoted in the 340B Report in connection with a U.S. Senate investigation into drug pricing practices and their broader impact on safety-net providers. The article examines a [...]

Feldesman Partner Kathy S. Ghiladi will speak at the American Health Law Association’s Medicare and Medicaid Institute, a leading national conference on Medicare and Medicaid policy and compliance, taking place March 18–20, [...]

Feldesman is proud to announce that six of its attorneys— Jesi J. Carlson, Philip A. Escoriaza, Adam J. Falcone, Kathy S. Ghiladi, Edward T. Waters, and Marcie H. Zakheim will speak at [...]

The U.S. District Court for the District of Maine has issued a temporary restraining order blocking the Health Resources and Services Administration’s (HRSA) 340B Rebate Model Pilot Program from taking effect on [...]

On Friday, September 12, 2025, the U.S. Court of Appeals for the Fifth Circuit issued an unpublished decision upholding a Mississippi law that protects 340B contract pharmacy arrangements. The ruling came in [...]

Feldesman Partner Marcie H. Zakheim will present two sessions at the 2025 Nebraska Community Health Conference, hosted by the Health Center Association of Nebraska (HCAN), on September 8–9, 2025 in Nebraska City, [...]

On August 1, 2025, the Office of Pharmacy Affairs (OPA) of the Health Resources and Services Administration (HRSA) announced a pilot rebate program for purchases under the 340B drug discount statute of [...]